To this end, we utilised antibodies against CD11b, HLA-DR and CD14 and CD16 followed by several gating steps (strategy C) to identify classical, intermediate and non-classical monocyte subtypes in healthy subjects, and also in patients with CHD and STEMI. Here, CD14 is linked to coronary artery disorder.